European Congress of Radiology (ECR) 2012 opened

The European Congress of Radiology (ECR), the annual meeting of the die European Society of Radiology (ESR), started on Thursday in Vienna. 20,000 visitors are expected to participate in the congress which is one of the largest healthcare events worldwide.

Lorenzo Bonomo
Lorenzo Bonomo

This year’s programme will focus on emergency radiology and oncologic imaging. “We want to promote the multidisciplinary exchange and the cooperation with these important areas of radiology”, underlined Professor Dr Lorenzo Bonomo, Congress President and Chairman of the Departments of Radiological Sciences and Bioimaging at A. Gemelli Hospital in Rome. At the opening press conference, however, other topics took centre stage.

One was the role of radiology in AIDS/HIV. While on the one hand the number of opportunistic infections has decreased significantly thanks to the new antiretroviral therapies, on the other hand increasing numbers of neurological and cognitive disorders are being recorded since HIV attacks the brain within days of the infection and settles there.

“Radiologists have to be aware of the changing pathologies in order to be able to directly detect not only sub-clinical manifestations of the HIV infection in the brain but also therapy-related effects”, emphasized Dr Majda M. Thurnher, Professor at the University Clinic for Radiodiagnostics at the Medical University Vienna. “In the course of the therapy lesions can tend to grow and can appear suspicious in an MR image“, Thurnher explained, for example when the immune reconstitution inflammatory syndrome (IRIS) is present. The challenge for the radiologist, according to Thurnher, is to be able to differentiate between this syndrome, which is an overreaction of the immune system, and manifestations of the disease.

Another issue that continues to be hotly debated in the radiology community surfaced at the press conference: the value of breast cancer screening. “Breast imaging is associated with the risk of overimaging and overdiagnosis. Moreover even screening will never be able to detect all cancers”, said Matthew G. Wallis, MB, ChB, FRCR, radiologist at the Cambridge Breast Unit and the NIHR Cambridge Biomedical Research Centre, and added that “this is always an issue of benefit versus damage.

” The question whether screening programmes for women under 50 years of age really lead to a decrease in the mortality rate, Wallis said, at this point cannot be answered conclusively. Surely, he added, more breast cancers would be diagnosed, the overall benefits for the population as a whole however cannot be predicted since the number of false positives will also increase - with all the financial and psychological consequences.

The European Congress of Radiology (ECR) 2012 in Vienna will run through 5 March. By Michael Krassnitzer.
 

01.03.2012

Read all latest stories

Related articles

Photo

GE invests in technology to tackle challenges in healthcare

Times may be tough, but GE Healthcare takes a longer term view, believing innovative technologies can transform healthcare delivery and help improve patient care.

Photo

Breast cancer screening

Spanish experts clash over benefits and harms

Breast cancer screening has helped to detect cancer in its early stages, but it is unclear how important this contribution is to mortality reduction because treatment has greatly improved.…

Photo

Finding early stage cancers that could have been missed

In Europe, 350,000 women are diagnosed with breast cancer annually. About 90% of them can be cured if the cancer is detected at a very early stage. To improve early detection almost all European…

Related products

Block Imaging

Surgical II-C-Arms

Block Imaging

Block Imaging
Canon – Alphenix Core

Single Plane

Canon – Alphenix Core

Canon Medical Systems Europe B.V.
Canon – Alphenix Core+

Single Plane

Canon – Alphenix Core+

Canon Medical Systems Europe B.V.
Canon – Alphenix Core+

Single Plane

Canon – Alphenix Core+

Canon Medical Systems Europe B.V.
Canon – Alphenix Hybrid

Single Plane

Canon – Alphenix Hybrid

Canon Medical Systems Europe B.V.
Canon – Alphenix Hybrid+

Single Plane

Canon – Alphenix Hybrid+

Canon Medical Systems Europe B.V.